Skip to content

Arcus Biosciences RCUS Free cash flow margin

Free cash flow margin at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
24.6%-2.9pp
Merck & Co. logo
Merck & Co.MRK
21.5%-5.2pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
27.6%+5.5pp
AbbVie logo
AbbVieABBV
31.8%+5.0pp
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-3,592%-4,290pp
Incyte logo
IncyteINCY
28.2%+19.7pp

Other financials

Income statement

See full
Revenue$17.0M-39.3%
Operating income-$134.0M-9.8%
Net income-$128.0M-14.3%
EPS (diluted)-$1.02+10.5%

Balance sheet

See full
Cash & equivalents$201.0M+4.7%
Total debt$113.0M+88.3%
Total equity$524.0M-1.3%
Total assets$997.0M-13.8%

Cash flow

See full
Operating cash flow-$138.0M-4.5%
CapEx--100%
Free cash flow-$138.0M-3.8%

Valuation

See full
Market cap$3.54B+226%
Enterprise value$3.46B+275%
P/S15×+7.3×

Profitability

See full
Operating margin-168.6%-52.7pp
Net margin-156.4%-47.5pp

Returns & leverage

See full
Return on equity-70%+8.4pp
Debt / equity0.2×+0.1×
Current ratio-1.3×

Where this comes from

Calculated from Arcus Biosciences’s reported figures.

Based on trailing twelve months.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arcus Biosciences's free cash flow margin?
Arcus Biosciences (RCUS) reported free cash flow margin of -207.2% in Q1 2026.
What is the long-term trend for Arcus Biosciences's free cash flow margin?
Over 2 years (2021 to 2025), Arcus Biosciences's free cash flow margin has grown at a 63.1% compound annual growth rate (CAGR), from -73.6% to -196%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.